tiprankstipranks
180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market

180 Life Sciences (ATNF) Financial Statements

215 Followers

180 Life Sciences Financial Overview

180 Life Sciences's market cap is currently ―. The company's EPS TTM is $-64.335; its P/E ratio is -0.03; 180 Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -12.60M$ -3.67M$ -4.82M$ -22.68M$ -21.48M
EBITDA$ -12.57M-$ -4.80M$ -24.64M$ -21.47M
Net Income Common Stockholders$ -10.00M$ -3.68M$ 4.41M$ -21.74M$ -21.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.66M$ 2.01M$ 2.65M$ 6.97M$ 3.59M
Total Assets$ 4.96M$ 13.67M$ 14.92M$ 19.65M$ 34.34M
Total Debt$ 355.10K$ 614.53K$ 842.20K$ 1.31M$ 437.97K
Net Debt$ -2.31M$ -1.39M$ -1.80M$ -5.66M$ -3.15M
Total Liabilities$ 5.11M$ 6.95M$ 7.78M$ 8.31M$ 8.26M
Stockholders Equity$ -149.33K$ 6.72M$ 7.14M$ 11.34M$ 26.08M
Cash Flow-
Free Cash Flow$ -1.78M-$ -3.87M$ -2.93M$ -3.60M
Operating Cash Flow$ -1.78M-$ -3.87M$ -2.93M$ -3.60M
Investing Cash Flow-----
Financing Cash Flow$ 2.45M--$ 6.40M$ 5.49M
Currency in USD

180 Life Sciences Earnings and Revenue History

180 Life Sciences Debt to Assets

180 Life Sciences Cash Flow

180 Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis